Australia's most trusted
source of pharma news
Thursday, 12 February 2026
Posted 12 February 2026 AM
Pfizer and Arrotex have formed a commercial partnership which will see Arrotex represent arthritis and psoriasis medication Enbrel across Australian community pharmacy, hospital pharmacy, and prescriber channels.
The deal came into effect from the start of February, with Enbrel integrated into Arrotex's established partnerships platform and Arrotex sales representatives engaging with aligned pharmacies.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.